相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
David R. Andes et al.
CLINICAL INFECTIOUS DISEASES (2012)
The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012
Nkechi Azie et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Topological and Mutational Analysis of Saccharomyces cerevisiae Fks1
Michael E. Johnson et al.
EUKARYOTIC CELL (2012)
Saccharomyces Genome Database: the genomics resource of budding yeast
J. Michael Cherry et al.
NUCLEIC ACIDS RESEARCH (2012)
Sodium Selenide Toxicity Is Mediated by O2-Dependent DNA Breaks
Gerald Peyroche et al.
PLOS ONE (2012)
Endocytosis-Mediated Vacuolar Accumulation of the Human ApoE Apolipoprotein-Derived ApoEdpL-W Antimicrobial Peptide Contributes to Its Antifungal Activity in Candida albicans
Tristan Rossignol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antifungal Activity of Colistin against Mucorales Species In Vitro and in a Murine Model of Rhizopus oryzae Pulmonary Infection
Ronen Ben-Ami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Synergistic Activities of Three Triazoles with Caspofungin against Candida glabrata Isolates Determined by Time-Kill, Etest, and Disk Diffusion Methods
Nuri Kiraz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Epidemiology of Invasive Mycoses in North America
Michael A. Pfaller et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2010)
Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro
Mark R. Harris et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect
Bing Zhai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity
Suzanne M. Noble et al.
NATURE GENETICS (2010)
French/European academic compound library initiative
Marcel F. Hibert
DRUG DISCOVERY TODAY (2009)
Synergistic fungicidal activities of polymyxin B and ionophores, and their dependence on direct disruptive action of polymyxin B on fungal vacuole
Akira Ogita et al.
JOURNAL OF ANTIBIOTICS (2009)
The changing face of epidemiology of invasive fungal disease in Europe
Cornelia Lass-Floerl
MYCOSES (2009)
New insights into sphingolipid metabolism and function in budding yeast
Robert C. Dickson
JOURNAL OF LIPID RESEARCH (2008)
The chemical genomic portrait of yeast: Uncovering a phenotype for all genes
Maureen E. Hillenmeyer et al.
SCIENCE (2008)
Stimulation of chitin synthesis rescues Candida albicans from echinocandins
Louise A. Walker et al.
PLOS PATHOGENS (2008)
New and emerging treatments for fungal infections
A. C. Pasqualotto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections
David L. Horn et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
Regulation of the transport and protein levels of the inositol phosphorylceramide mannosyltransferases Csg1 and Csh1 by the Ca2+ binding protein Csg2
Satoshi Uemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Joshua Perlroth et al.
MEDICAL MYCOLOGY (2007)
Palmitoylation by the DHHC protein Pfa4 regulates the ER exit of Chs3
Karen K. Y. Lam et al.
JOURNAL OF CELL BIOLOGY (2006)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
Sergey V. Balashov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: Importance of persistence of caspofungin in tissues to understanding drug activity
A Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Candida albicans strains deficient in CHS7, a key regulator of chitin synthase III, exhibit morphogenetic alterations and attenuated virulence
M Sanz et al.
MICROBIOLOGY-SGM (2005)
Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans
T Prasad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata
ER Oliveira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans
SM Noble et al.
EUKARYOTIC CELL (2005)
Analysis of β-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin
G Lesage et al.
GENETICS (2004)
Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters
M Karababa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of candida albicans ABC transporters CDR1 and CDR2
AT Coste et al.
EUKARYOTIC CELL (2004)
Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan β-mannosylation, reduces virulence, and alters cell wall protein β-mannosylation
C Mille et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae
S Markovich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Csg1p and newly identified Csh1p function in mannosylinositol phosphorylceramide synthesis by interacting with Csg2p
S Uemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Attributable mortality of nosocomial candidemia, revisited
O Gudlaugsson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Functional profiling of the Saccharomyces cerevisiae genome
G Giaever et al.
NATURE (2002)
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods
EE Roling et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections
AH Groll et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
分享论文
